CN109331022A - Improving female ovary function improves the composition and preparation process of female skin - Google Patents
Improving female ovary function improves the composition and preparation process of female skin Download PDFInfo
- Publication number
- CN109331022A CN109331022A CN201811421520.4A CN201811421520A CN109331022A CN 109331022 A CN109331022 A CN 109331022A CN 201811421520 A CN201811421520 A CN 201811421520A CN 109331022 A CN109331022 A CN 109331022A
- Authority
- CN
- China
- Prior art keywords
- weight
- blood
- parts
- factor
- iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Abstract
The present invention relates to improve female ovary function to improve the composition and preparation process of female skin.Specifically, one aspect of the present invention is related to a kind of pharmaceutical composition, wherein including X-factor and diluent, the diluent is selected from: starch, sucrose, lactose, microcrystalline cellulose, calcium monohydrogen phosphate.The invention further relates to the preparation processes for the composition for preparing raising female ovary function improvement female skin, further relate to purposes of the pharmaceutical composition of the present invention in the drug that preparation improves female skin for improving female ovary function.As described in the present invention, excellent biology effect is presented in the present composition.
Description
Technical field
The present invention relates to improving female ovary function to improve the composition and preparation process of female skin, specifically, originally
Invention is related to a kind of group for improving female skin using X-factor as raising female ovary function made of active constituent
Object is closed, more particularly, excellent biology is presented in the composition that raising female ovary function of the invention improves female skin
Effect.
Background technique
When demand and supply of the body to iron is unbalance, lead to store iron loss in vivo to the greatest extent (ID), followed by Erythrocyte Iron lacks
(IDE), finally cause hypoferric anemia (IDA).IDA is the terminal stage of asiderosis (including ID, IDE and IDA), is shown as
Microcytic hypochromic anemia caused by iron deficiency and other exceptions.IDA is the most common anaemia.Its disease incidence is in development China
Family, economically less developed region and infant, the women of child-bearing age obviously increase.Shanghai population investigation display: the year of asiderosis
Disease incidence is in 6 months~2 years old infant 75.0%~82.5%, 3 months pregnant or more women 66.7%, the women of child-bearing age
43.3%, 10 years old~17 years old teenager 13.2%;The above crowd IDA illness rate is respectively 33.8%~45.7%, 19.3%,
11.4%, 9.8%.It is main related to following factors to suffer from asiderosis: the addition of infant's diatery supplement is insufficient, teenager's partial eclipse, women
Excessive menstruation/multiple pregnancies/lactation and certain pathological factors (the big portion's excision of such as stomach, chronic blood loss, chronic diarrhea, atrophic
Gastritis and hookworm infection etc.) etc..The multiple group of hypoferric anemia is infant, Women of childbearing age.The common disease of hypoferric anemia
Shape is out of strength, easy tired, dizziness headache, dim eyesight, tinnitus, palpitaition etc..
The common disease factor of hypoferric anemia is caused by chronic wasting disease, malnutrition, hookworm infection etc..Under in addition,
Column reason is also the common disease factor of hypoferric anemia: 1. need iron increase and iron insufficiency of intake: be more common in infant, teenager,
Gestation and breast feeding women.Infant needs iron more, if not supplementing the higher diatery supplement of the iron-content such as eggs, meat, easily causes
Iron deficiency.The easy iron deficiency of teenager's partial eclipse.Feminine menstrual increases, gestation or lactation, needs iron to increase, if not supplementing high-speed rail food, easily
Cause IDA.2. iron malabsorption: being common in Partial gestrectomy, gastric acid secretion is insufficient and food rapidly enters jejunum, bypasses
The major absorption site (duodenum) of iron absorbs iron and reduces.In addition, functional disturbances of gastrointestinal tract caused by many reasons, such as
Because of iron malabsorption IDA can occur for long-term unknown cause diarrhea, chronic enteritis, clone's disease etc..3. iron is lost excessive: chronic
Long-term iron is lost and cannot be corrected, and IDA is caused.Such as: chronic gastrointestinal blood loss (including hemorrhoid, gastroduodenal ulcer, food
Pipe ceasma hernia, gastrointestinal polyps, gastroenteric tumor, parasitic infection, oesophagus/Therapy for Gastric Variceal etc.), excessive menstruation
(Pulmonary hemosiderosis is calm for (in utero placing the gynecological diseases such as intrauterine device, fibroid and menstrual disorder), hemoptysis and alveolar bleeding
Disease, Goodpasture syndrome, pulmonary tuberculosis, bronchiectasis, lung cancer etc.), hemoglobinuria (the blood red egg of paroxysmal nocturnal
Albiduria, cold anitibody type autoimmune hemolytic anemia, artificial cardiac valve prosthesis, march hemoglobinuria etc.) and other (heredity bleedings
Property telangiectasia, is repeatedly donated blood at the haemodialysis of chronic renal failure row).
It is current clinically more efficient method that anaemia is treated by taking X-factor.Ferric sesquichloride blood
Red pigment, also known as hemin, hydrochloric acid ferroheme, hemin, heme iron etc. are the purification shapes of natural ferroheme
Formula is typically separated from animal blood, purifies out.Heme iron is pure natural biological iron supplementary, has biology
The advantages that availability is high, without the adverse reactions such as internal iron accumulation of poisoning and gastrointestinal irritation.Having test confirms that heme iron is small
The absorptivity of enteral at most only has 25% (and nonheme iron is lower, about 3%~8%), without any side reaction, and not by meals
Food and other factors influence, and are ideal iron supplementaries.Increasingly by people's due to it can be developed as health food, beverage
Favor.The important raw material of ferroheme or anti-anemia action and anti-tumor drug, U.S. FDA are formally criticized July nineteen eighty-three simultaneously
The hemin of quasi- Abbott is used as drug.
X-factor, Hemin, CAS registration number 16009-13-5, molecular formula C34H32ClFeN4O4, molecule
Amount is 651.94, chemical structural formula are as follows:
The prior art has many reports in relation to X-factor relevant clinical treatment technology.For example,
(application number: 94100393.0) be related to a kind of food additive for supplementing iron and preparation method, feature is the additive to CN1105206A
Main component can be directly made of by the hemin that intestinal wall cell is absorbed what is extracted from animal blood, prepare
Method is that stock-smashs the clot solidified to pieces erythroblast liquid-plus complete hemolysis liquid is made in water-is added to and is heated
In the glacial acetic acid of sodium chloride-containing and continuously stir-sediment separate out-washing-ethyl alcohol wash-dries finished product.The present invention is without bloody
Taste or metallic taste, it is non-toxic, meet food additives sanitary standard, can be used in beverage, biscuit and candy, absorption is not eaten
Other ingredient interference in object, mend iron, eliminate-poverty blood is better than common ferrous gluconate.
CN108065207A (application number: 201610996261.2) being related to a kind of X-factor health food,
Each component parts by weight are respectively as follows: 4-8 parts of Turmeric P.E, 2-5 parts of Fructus Jujubae extract, 1-3 parts of Sanguis Draxonis extract, carrot and mention
3-6 parts of object, king is taken not to stay 2-6 parts of extract, 1-3 parts of black bean powder, 10-18 parts of X-factor.Selected by the present invention
Raw material proportioning is scientific and reasonable, proves through human feeding trial, suitable for the anaemia of physiological function decline and dystrophic, to scarce
Iron anaemia, hemolytic anemia, leukanemia and hypoproliferative anemia all have good improvement result.
CN106858017A (application number: 201710045539.2) discloses a kind of rich melt quality soft sweets, wraps in the soft sweets
Chloride containing protoferriheme and longan extract, wherein the content of X-factor is 1~5g/100g, longan extract
Content be 1~10g/100g.The invention also discloses the preparation methods of the richness melt quality soft sweets.Rich melt quality of the invention is soft
Sugar has the effect of excellent benefit iron, improves anaemia, and mouthfeel is good, easy to carry, is suitble to all kinds of people including children and pregnant woman
The daily health caring of group is edible.
CN103536670A (application number: 201310485725.X) is related to the composition from plant, proposes that one kind is used for
Improve the composition of alimentary anemia, the component including following weight parts: 100-200 parts of Fructus Jujubae extract, ferric sesquichloride is blood red
It is 30-50 parts plain, 200-300 parts of auxiliary material.Composition proposed by the present invention selects Southern Xinjiang to produce day jujube, full of nutrition, tool
There is the fabulous effect that fills blood, in conjunction with X-factor, had not only improved user's taste situation, augment nutritional absorption, but also straight
Connect supplement ferroheme.And stimulation will not be generated to user's stomach.
CN103005118A (application number: 201210581612.5) discloses a kind of iron-supplementing fudge.Benefit iron of the present invention
Soft sweets are made of maltitol, X-factor, gelatin, pectin, agar, citric acid, malic acid and fruit juice.The present invention with
X-factor is to mend iron material, using agar, gelatin, pectin and maltitol as base saccharic composition, is aided with citric acid, apple
Acid and fruit juice prepare a kind of iron-supplementing fudge, on the basis of guaranteeing iron-supplementing fudge high stability, being less prone to the water outlet of sugared body,
Also there is preferably quality in taste, chewiness, elasticity, hardness.
CN101822367A (application number: 200910079050.2) is disclosed a kind of with improving alimentary anemia function
Pharmaceutical composition and preparation method thereof.The pharmaceutical composition is by spirulina phycocyanin 5-60%, Catergen -40%, dimension
Raw element B21-10%, X-factor 1-50% are prepared.It is believed that the invention pharmaceutical composition, which has, improves trophism
The function of anaemia.
To enough iron is supplemented in vivo, promote isohydria, it will help improving female ovary function improves female skin.
However the effect of existing X-factor preparation still has etc. and to improve, especially because the absorption of X-factor
Deal is still lower.Therefore, X-factor properties of product are improved to improve its clinical effectiveness, are still this field skill
Art personnel urgently expect.
Summary of the invention
The purpose of the present invention is to provide a kind of X-factor composition with excellent performance, of the invention is another
One method for being designed to provide preparation the composition.
For this purpose, first aspect present invention provide it is a kind of for improve female ovary function improve female skin medicine group
Object is closed, wherein including X-factor and diluent.
Pharmaceutical composition according to a first aspect of the present invention, wherein the diluent is selected from: starch, sucrose, lactose, micro-
Crystalline cellulose, calcium monohydrogen phosphate etc..
Pharmaceutical composition according to a first aspect of the present invention, wherein also including phosphatide.Such as egg yolk lecithin, soybean lecithin
Rouge etc..
Pharmaceutical composition according to a first aspect of the present invention, wherein including 100 parts by weight of X-factor, diluent
100~1000 parts by weight, phosphatidase 1~25 parts by weight.
Pharmaceutical composition according to a first aspect of the present invention, wherein including 100 parts by weight of X-factor, diluent
100~750 parts by weight, phosphatidase 5~15 parts by weight.
Pharmaceutical composition according to a first aspect of the present invention, wherein including 100 parts by weight of X-factor, diluent
100~500 parts by weight, phosphatidase 5~10 parts by weight;Such as 100 parts by weight of X-factor, 300 parts by weight of diluent, phosphorus
7.5 parts by weight of rouge.
Pharmaceutical composition according to a first aspect of the present invention is to be prepared according to the method included the following steps: making
X-factor is crushed to the fine powder that can pass through 100 mesh screens in advance;It is dissolved in phosphatide in ethyl alcohol and concentration 20 is made
~25% solution;Phospholipid solution is sprayed in fluidisation in 30~35 DEG C of fluidizing equipments (such as fluidised bed granulator)
In the X-factor fine powder of state, continues fluidisation and remove ethyl alcohol;The diluent that 20~30 parts by weight are added is uniformly mixed,
Material is compressed into tablet form object with extruder;This tablet is set -20~-15 DEG C to freeze 24~30 hours;Tablet is crushed,
Balance diluents are added to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;It is in optionally fine-powdered by this
Composition dosage form is made.It has been unexpectedly discovered that making X-factor after by uniformly adding phosphatide
Material is compressed into tablet form object, then the tablet is freezed, and crushes, and the X-factor in gained fine powder presents excellent molten
Solve performance and dissolving out capability.
Pharmaceutical composition according to a first aspect of the present invention, wherein the dosage form is tablet, capsule, soft capsule
Any applicable preparation of agent, pill, powder, granule, electuary, oral mixed suspension liquor, dry suspensoid agent, paste, jelly agent etc.
Form.Preferred dosage form is tablet, capsule, soft capsule, granule, dry suspensoid agent.
Further second aspect of the present invention provides the preparation any implementation of pharmaceutical composition such as first aspect present invention
The method of scheme described pharmaceutical composition includes X-factor and diluent in described pharmaceutical composition.
Method according to a second aspect of the present invention, wherein the diluent in described pharmaceutical composition is selected from: starch, sucrose,
Lactose, microcrystalline cellulose, calcium monohydrogen phosphate etc..
Method according to a second aspect of the present invention wherein also includes phosphatide in described pharmaceutical composition.Such as yolk lecithin
Rouge, soybean lecithin etc..
Method according to a second aspect of the present invention wherein includes 100 weight of X-factor in described pharmaceutical composition
Measure part, 100~1000 parts by weight of diluent, phosphatidase 1~25 parts by weight.
Method according to a second aspect of the present invention wherein includes 100 weight of X-factor in described pharmaceutical composition
Measure part, 100~750 parts by weight of diluent, phosphatidase 5~15 parts by weight.
Method according to a second aspect of the present invention wherein includes 100 weight of X-factor in described pharmaceutical composition
Measure part, 100~500 parts by weight of diluent, phosphatidase 5~10 parts by weight;Such as 100 parts by weight of X-factor, diluent
300 parts by weight, 7.5 parts by weight of phosphatide.
Method according to a second aspect of the present invention comprising following steps: X-factor is made to be crushed to energy in advance
Pass through the fine powder of 100 mesh screens;Phosphatide is set to be dissolved in the solution that concentration 20~25% is made in ethyl alcohol;In 30~35 DEG C of stream
Change and phospholipid solution be sprayed in the X-factor fine powder in fluidized state in equipment (such as fluidised bed granulator),
Continue fluidisation and removes ethyl alcohol;The diluent that 20~30 parts by weight are added is uniformly mixed, and material is compressed into tablet form object with extruder;
This tablet is set -20~-15 DEG C to freeze 24~30 hours;Tablet is crushed, balance diluents are added and are mixed, continue to crush
Extremely composition can be obtained by the fine powder of 60 meshes;Dosage form optionally is made in the composition of fine-powdered in this.Go out
It finds to people's will material, after by uniformly adding phosphatide, X-factor material is made to be compressed into tablet form object, then by the sheet
Object freezing, crushes, and excellent solubility property and dissolving out capability is presented in the X-factor in gained fine powder.
Method according to a second aspect of the present invention, wherein the dosage form be tablet, capsule, soft capsule, pill,
Any applicable dosage form of powder, granule, electuary, oral mixed suspension liquor, dry suspensoid agent, paste, jelly agent etc..It is preferred that
Dosage form be tablet, capsule, soft capsule, granule, dry suspensoid agent.
Method according to a second aspect of the present invention, obtained by pharmaceutical composition for improve female ovary function improvement
Female skin.
Further, third aspect present invention, which provides pharmaceutical composition, improves in preparation for improving female ovary function
Purposes in the drug of female skin includes X-factor and diluent in described pharmaceutical composition.
Purposes according to a third aspect of the present invention, wherein the diluent is selected from: starch, sucrose, lactose, microcrystalline cellulose
Element, calcium monohydrogen phosphate etc..
Purposes according to a third aspect of the present invention wherein also includes phosphatide in described pharmaceutical composition.Such as yolk lecithin
Rouge, soybean lecithin etc..
Purposes according to a third aspect of the present invention wherein includes 100 weight of X-factor in described pharmaceutical composition
Measure part, 100~1000 parts by weight of diluent, phosphatidase 1~25 parts by weight.
Purposes according to a third aspect of the present invention, wherein in described pharmaceutical composition in include X-factor 100
Parts by weight, 100~750 parts by weight of diluent, phosphatidase 5~15 parts by weight.
Purposes according to a third aspect of the present invention, wherein in described pharmaceutical composition in include X-factor 100
Parts by weight, 100~500 parts by weight of diluent, phosphatidase 5~10 parts by weight;Such as 100 parts by weight of X-factor, dilution
300 parts by weight of agent, 7.5 parts by weight of phosphatide.
Purposes according to a third aspect of the present invention, wherein described pharmaceutical composition is according to the method preparation included the following steps
It obtains: X-factor being made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is dissolved in ethyl alcohol to be made
The solution that concentration is 20~25%;Phospholipid solution is sprayed in 30~35 DEG C of fluidizing equipments (such as fluidised bed granulator)
In X-factor fine powder in fluidized state, continues fluidisation and remove ethyl alcohol;The diluent of 20~30 parts by weight is added
It is uniformly mixed, material is compressed into tablet form object with extruder;This tablet is set -20~-15 DEG C to freeze 24~30 hours;By piece
Shape object is broken, and balance diluents are added and are mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;Optionally will
Dosage form is made in the composition of fine-powdered in this.It has been unexpectedly discovered that making chlorination after by uniformly adding phosphatide
Protoferriheme material is compressed into tablet form object, then the tablet is freezed, and crushes, and the X-factor in gained fine powder is in
Existing excellent solubility property and dissolving out capability.
Purposes according to a third aspect of the present invention, wherein the dosage form be tablet, capsule, soft capsule, pill,
Any applicable dosage form of powder, granule, electuary, oral mixed suspension liquor, dry suspensoid agent, paste, jelly agent etc..It is preferred that
Dosage form be tablet, capsule, soft capsule, granule, dry suspensoid agent.
In the method and step that describes of the present invention, although the specific steps of its description are in certain details or language description
Step different from described in the upper and example of following detailed description part, however, those skilled in the art according to
The detailed disclosure of full text of the present invention can summarize approach described above step completely.
Any embodiment in either present invention face can be combined with other embodiments, as long as they are not
It will appear contradiction.In addition, any technical characteristic can be adapted for other realities in any embodiment of either side of the present invention
The technical characteristic in scheme is applied, as long as they are not in contradiction.
The invention will be further described below.
All documents recited in the present invention, their full content are incorporated herein by reference, and if these are literary
When offering expressed meaning and the inconsistent present invention, it is subject to statement of the invention.In addition, the various terms that use of the present invention and
Phrase has that well known to a person skilled in the art general senses, nonetheless, the present invention remain desirable at this to these terms and
Phrase is described in more detail and explains, the term and phrase referred to is if any inconsistent with common art-recognized meanings, with institute's table of the present invention
Subject to the meaning stated.
The reason of anaemia one of the most common, be hypoferric anemia or alimentary anemia.If intake of the human body to iron
Amount is insufficient, will influence the synthesis of hemoglobin, so that the content of hemoglobin in red blood cell is substantially reduced, it is red thin therewith
Born of the same parents' number is just reduced.As a result, intracorporal each cell, tissue can be made one for hypoxgia, iron-deficiency anemia will lead to.
Anemic patients with preschool child, pregnant woman, the women of child-bearing age be it is most, be deficiency disease important in the world it
One.According to the investigation of Chinese Academy Of Preventive Medicine Research Institute Of Nutrition And Food Hygiene in 1986, in 4747 preschool children
In, the patient of hypoferric anemia accounted for 59.1%, and with 6 months to 1 years old child morbidity rate highests.Nineteen ninety, Shanghai City was to several
The investigation in nursery also indicates that child suffers from that hypoferric anemia is more universal, accounts for about the 30~40% of respondent's number.1984
Autumn, Zhejiang Province's nutrition survey have 33.1% people as a result, in the hemoglobin of 1035 people, are in iron deficiency state.Wherein city
City resident is 51.9%, and peasant 40.1%, and university student 48.3%, elementary urban school raw up to 68.3%.It is taken in again according to iron
The investigation of amount, the iron intake of Zhejiang Province various people, between 18.0~88.3 milligrams, account for supply standard 180~
736%.It is indicated above that source of iron is quite abundant from the point of view of the iron-content in food.Again from the point of view of food qualification category, source of iron master
To come from plant food.But the iron of plant food, absorptivity are extremely low.If rice is only 1%, wheat 5%, spinach
It is 7% with soybean.On the contrary, the absorptivity of meat and liver is higher, about 22%.Such as it is by the average absorption ratio of iron in food
10% calculates, then averagely everyone iron for being absorbed and utilized daily, and only 1.8~8.88 milligrams.Certainly, such case has been in recent years
Improve, but the iron being utilized is still insufficient.Therefore, other than paying attention to the supplement of Dietary Iron, another key factor is,
The suction that raising iron must further be made great efforts is put and utilization rate.
In terms of the cardinal symptom of hypoferric anemia, hemoglobin is a kind of iron protein of red, wherein the quantity of iron
Account for about the 70~80% of the total iron-content of human body.The main component of red blood cell is hemoglobin.Red blood cell transports the work of oxygen, just
It is completed by hemoglobin.Iron is a kind of valence variation element, there is ferroso-ferric oxide, di-iron trioxide and three kinds of ferrous oxide.
When becoming another valence state from a kind of valence state due to iron, the energy for needing to consume (or releasing) is few, thus is oxygen in blood
Good carrier.After blood enters lung, the iron in red blood cell is combined with fresh oxygen, and iron just from becoming high price at a low price;Work as blood
When liquid enters other positions of body, iron in red blood cell then from becoming at high price at a low price, and releases oxygen.At this point, cardinal symptom
It showing themselves in that 1. due to for hypoxgia, intracorporal blood more flows to important organ, and the internal organs that those temporary influences are little,
Such as the blood vessel of skin, mucous membrane etc. then starts to shrink.Then it often will appear skin, mucous membrane etc. bleaches in eyelid.This phenomenon exists
The parts such as lip, nail and ear-lobe are particularly evident.2. occurring since the enough oxygen of cell can not be supplied so as to cause body various
It is uncomfortable: to be short of breath, palpitate quickly, is out of strength, fatiguability, appetite stimulator and drowsiness etc..3. hypoferric anemia is also easy to cause
Intracerebral anoxic, influences right mind, makes elaborative faculty variation, amnesia and dizziness, dim eyesight, tinnitus etc. often occurs.For 2 years old
Within infant, also will have a direct impact on the normal development of brain and body.In addition, iron deficiency also affects the synthesis of protein
With the utilization of energy, insulting immunologic mechanism leads to the disorder of inorganic salts and vitamin metabolism, is detained lead, magnesium, cobalt,
The uptake of zinc increases, and ascorbic content is reduced in blood, and the number of blood platelet increases.Also it can cause internal drug effect
With the no-load voltage ratio of metabolism, increase the excretion of succinic acid and ketoboidies in urine.
Hypoferric anemia onset is slow.When the iron lazy weight daily intaked, anaemia can't occur immediately, but it is sharp
With the iron storeed in body.When the iron of reserve is finished, and starts the tendency for anaemia occur, also will not all occur above-mentioned disease immediately
Shape or even majority feel unobvious.When patient goes to see a doctor, it is poor that the state of an illness has generally all had developed to moderate
Blood.Therefore, often pay attention to the supplement of iron, and make the reserve for having certain amount iron in vivo, just can guarantee the health of body.
X-factor is the ferroheme crystallization for purifying out from animal blood, chemical property and ferroheme class
Seemingly.Hemin is crystallization or powder, and light transmission is dark brown, and refractive power is chalybeate, odorless, tasteless, not soluble in water and acetic acid,
It is slightly soluble in 70%~80% ethyl alcohol, acid acetone is dissolved in, is dissolved in diluted sodium hydroxide solution, it is high that hydroxyl is generated in sodium hydroxide solution
Iron ferroheme.
Ferroheme is primarily present in the blood and muscle of animal, is the natural pigment in animal blood.Ferroheme be by
Protoporphyrin IX and iron (II) complexing are formed, and it is in black-and-blue for crystallizing, not soluble in water, acid acetone, alkaline aqueous solution are dissolved in, in solution
In easily form polymer.There is resonant structure in its molecule, property is stablized.Compound protein can be combined into protein, i.e., it is blood red
Albumen (Hb) or myoglobins (Mb).Hb is transport O2It is the buffer substance for maintaining blood pH constant with the carrier of part CO.?
Under certain condition, ferroheme and Separation of Proteins can be made.
Hemin is generally extracted from pig blood, in medicine, food, chemical industry, health care product, building and cosmetic industry
In be widely used.In the food industry, hemin can replace colour former nitrite and artificial conjunction in meat products
At pigment;In pharmaceutical industry, it can be used as semi-synthetic bilirubin raw material, and can be used for preparing anticancer specific drug;In clinic
On, it can be made into ferroheme iron supplementary;In cosmetics industry, it is a kind of important raw material.
Hemin has bioavilability height, pierces without internal iron accumulation of poisoning and stomach and intestine as irony hardening agent
Swash the advantages that waiting adverse reactions.This is because hemin is absorbed with molecular forms, can directly be absorbed by intestinal mucosa.Chlorination
Ferroheme is the generally acknowledged prevention and treatment hypoferric anemia of modern medicine, the biological source of iron that absorptivity is high, effect is good, and no iron taste does not pierce
Swash stomach and intestine, be infant, pregnant woman's first choice benefit iron enrich blood product.
Mainly there are ultraviolet spectroscopy, fluorescence method, infrared light about the article of hemin detection method and report at present
Spectrometry, polarography, visible spectrophotometry, electrode method etc..It is ultraviolet with infra-red sepectrometry: two kinds of spectroscopic methodology principles are similar,
It is to be compared using standard items with the infrared light scanning spectrogram and ultraviolet light of sample scanning spectrogram, to the trend and change of map
Change trend is compared.In infrared light scanning spectrogram, if sample and standard items Absorption Characteristics having the same, spectrogram is scanned
Shape is unanimous on the whole, can illustrate test gained sample as hemin using this.In ultraviolet light scanning spectrogram, standard items exist
Wavelength is to have absorption maximum within the scope of 380-410nm, but because the difference of solvent, will lead to the maximum absorption wavelength of standard items
Also different.Under same experimental conditions, if sample has absorption maximum at Same Wavelength, it is blood red that this method can be used as chlorination
The Qualitative Identification of element.Yuan Xi detects hemin oral solution using ultraviolet spectroscopy to its hemin content,
Wavelength is used to be measured to fight the hemin in poor take orally at 384nm, the results showed that in 1.80-9.10ug/mL line
Within the scope of property, R=0.9999, standard deviation is 0.67%, and the average recovery rate of method reaches 99.3%.Fluorescence method is using blood red
The fluorescent characteristic of plain mesoporphyrin, can detect that the fluorescence intensity of sample using fluophotometer, so that it is corresponding blood red to calculate it
Cellulose content, such as the quantitative determination of ferroheme in excrement, it is ferroheme that hemoglobin is cleared up in enteron aisle, and ferroheme is thin in enteron aisle
Under the action of bacterium, its corresponding content of hemachrome can be calculated using the fluorescent characteristic of porphyrin for porphyrin by being largely resolved.Blood
Red pigment and oxalic acid reagent heat together can slough ferrous ion, and be reduced into the porphyrin with fluorescent characteristic, under this condition using glimmering
Porphyrin measured by light method is ferroheme amount whole in enteron aisle.The ferroheme of resolution is ferroheme intestines divided by ferroheme total amount
Road conversion ratio is digested longer when absorption since bleeding part is higher, and the conversion ratio of enteron aisle is also higher, so from enteron aisle
Conversion ratio can probably extrapolate the position of intestinal bleeding.Visible spectrophotometry: ferroheme is dissolved in 0.25%
It is to have maximum absorption peak, hydrochloric acid acetone method extraction process of the Yang Shuqin in ferroheme at 610nm in wavelength in Na2CO3 solution
In the useful method content of ferroheme is measured.Polarography: the polarographic behaviour by studying ferroheme, with 0.1mol/L
There is a sensitive cathodic wave in -0.42V point as buffer solution, ferroheme in NH3-NHCl.It can detect that using this method
Minimum hemoglobin concentration is 8 × 10mol/L.Electrode method: the method detects ferroheme using the graphite electrode after modification, finds electrode
It is sensitiveer to the concentration-response of ferroheme, concentration within the scope of 1 × 10~1 × 10mol/L ferroheme and electrode reaction at line
Sexual intercourse.Other methods: other than above method, there are also some methods about measurement hemin.Yuan Xi is in water-bath
Hemin is dissolved using sodium hydroxide solution under heating heating condition, sulfuric acid is added after cooling, is generated immediately after rolling is even
Brown precipitate.Filtrate is taken to add ammonium thiocyanate test solution few drops after filtering, solution is in brownish red.It is blood red that this chromogenic reaction can be used as chlorination
The qualitative detection of element.
The pathogenic factor of hypoferric anemia mainly has, and 1. need iron to increase and iron insufficiency of intake: being more common in infant, blueness less
Year, gestation and breast feeding women.Infant needs iron relatively to add, if not supplementing the higher diatery supplement of the iron-content such as eggs, meat, Yi Zao
At iron deficiency.The easy iron deficiency of teenager's partial eclipse.Feminine menstrual increases, gestation or lactation, and iron is needed to increase, if not supplementing high-speed rail food,
Easily cause IDA.2. iron malabsorption: it is common in Partial gestrectomy, gastric acid secretion is insufficient and food rapidly enters jejunum, around
The major absorption site (duodenum) for crossing iron absorbs iron and reduces.In addition, functional disturbances of gastrointestinal tract caused by many reasons,
Because of iron malabsorption IDA can occur for such as long-term unknown cause diarrhea, chronic enteritis, clone's disease.3. iron is lost excessive: slow
Property long-term iron lose and cannot correct, cause IDA.Such as: chronic gastrointestinal blood loss (including hemorrhoid, gastroduodenal ulcer,
Hiatal hernia, gastrointestinal polyps, gastroenteric tumor, parasitic infection, oesophagus/Therapy for Gastric Variceal etc.), menstrual flow mistake
(Pulmonary hemosiderosis is heavy for more (in utero placing the gynecological diseases such as intrauterine device, fibroid and menstrual disorder), hemoptysis and alveolar bleeding
Disease, Goodpasture syndrome, pulmonary tuberculosis, bronchiectasis, lung cancer etc.), (paroxysmal nocturnal is blood red for hemoglobinuria
Albuminuria, cold anitibody type autoimmune hemolytic anemia, artificial cardiac valve prosthesis, march hemoglobinuria etc.) and other (heredity goes out
Hemorrhagic telangiectasia, is repeatedly donated blood at the haemodialysis of chronic renal failure row).
The clinical manifestation of hypoferric anemia mainly has following aspect, 1. iron deficiency protopathy performance: as menstruation quantity is more, disappears
Change abdominal pain/stool caused by melena/bloody stool/abdominal discomfort, intestinal parasitism caused by road ulcer/tumour/hemorrhoid
Change, the syntexis of tumor disease, hemoglobinuria etc..2. anaemia shows: it is out of strength, easily tired, dizzy, headache, dim eyesight, tinnitus,
Palpitaition, shortness of breath, poor, pale, increased heart rate of receiving.3. organizing iron deficiency performance: mental act is abnormal, and such as agitation, irritability, attention are not
It concentrates, allotriophagy;Physical strength, endurance decline;Easy infection;Upgrowth and development of children is slow, feeblemindedness;Stomatitis, glossitis, lingual papilla
Atrophy, bicker chap, dysphagia;Hair dries up, falls off;Dry skin, shrinkage;Refer to (toe) onychomadesis gloss, thin and brittle easy to crack,
Severe one refers to that (toe) first flattens or even concave in spoon shape (coelonychia).
Whether by checking the generation that may determine that hypoferric anemia as follows, 1. blood pictures are in microcytic hypochromic anemia.
Mean corpuscular volume (MCV) (MCV) < 80fl, mean corpusular hemoglobin (MCH) < 26pg, mean corpuscular hemoglobin
Concentration (MCHC) is less than 0.32.Visible red cell body is small in Blood piece, center understain area expands.Reticulocyte count it is mostly normal or
Slightly increase.Leucocyte and platelet count can be normal or lower.2. bone marrow smear, active proliferation or obvious active;With the increasing of red system
Based on life, grain system, macronucleus system Non Apparent Abnormality;In red system in, based on metarubricyte, it is small in size, nuclear chromatin is fine and close,
Endochylema is few, edge is irregular, has hemoglobin to form bad performance (" core starches children always ").3. iron metabolism, bone marrow smear is ferrous
After potassium cyanide (Prussian blue reaction) dyeing, without navy blue hemosiderin granule in marrow granule, in normoblast
Iron granule is reduced or is disappeared, and sideroblast is less than 0.15;Serum ferritin reduces (< 12 μ g/L);Serum levels of iron reduces (< 8.95 μ
Mol/L), total iron binding capacity increases (>64.44 μm of ol/L), and Transferrin turation reduces (<15%).(solubility turns iron to sTfR
Protein receptor) concentration is more than 8mg/L.4. porphyrin metabolism in red blood cell, FEP (free erythrocyte protoporphyrin) > 0.9 μm ol/L is (complete
Blood), ZPP (zinc protoporphyrin) > 0.96 μm ol/L (whole blood), FEP/Hb (hemoglobin) > 4.5 μ g/gHb.
Further identify small cell anemia by following antidiastole, 1. sideroblastic anemias: hereditary or unknown
Erythrocyte iron use aplastic anemia caused by reason.Small cell anemia is showed, but serum ferritin concentration increases, marrow is small
Hemosiderin granule increases grain, sideroblast increases, and ringed sideroblasts occurs.Serum levels of iron and iron saturation degree increase
Height, total iron binding capacity be not low.2. thalassemia: there is family history.There is haemolysis performance.Visible volume target erythrocyte in Blood piece.
Fetal hemoglobin or HbA2 increase.Serum ferritin, marrow can contaminate iron, serum levels of iron and iron saturation degree is low and normal increasing
It is high.3. anemia of chronic disease: Abnormality of Iron Metabolism anaemia caused by chronic inflammation, infection or tumour etc..Anaemia is cellule type.Storage
Iron (serum ferritin and marrow granule hemosiderin) increases.Serum levels of iron, serum iron saturation, total iron binding capacity lower.4.
Atransferrinemia: autosomal recessive inheritance (congenital) or severe liver disease, tumour are secondary (acquired).It shows as small thin
Born of the same parents' hypochrosis microcytic anemia.Serum levels of iron, total iron binding capacity, serum ferritin and marrow hemosiderin are substantially reduced.It is congenital,
Child's morbidity is involved with depauperation and multi-organ function.It is acquired, there is protopathy performance.
The treatment of hypoferric anemia mainly carries out from the following aspect, 1. principles of reatment: the principle for treating IDA is: 1. eradicating
The cause of disease;2. supplying storage iron.2. etiological treatment: IDA caused by infant, teenager and gravid woman's subalimentation should improve drink
Food.IDA caused by menstruation is more answers regulating menstruation.Parasitic infection answers antihelminthic chemotherapy.Malignant tumour, should perform the operation or Radiotherapy chemotherapy;On
Digestive tract ulcer answers acid suppression treatment etc..3. iron supplement therapy: therapeutic chalybeate has two class of inorganic iron and Organic Iron.Inorganic iron is with sulphur
Sour ferrous iron is representative, and organic iron rule includes iron-dextrin, ferrous gluconate, Iron Sorbitex, ferrous fumarate and polyferose
Compound etc..The more organic chalybeate of the side reaction of inorganic chalybeate is obvious.Preferred Oral Iron Preparations.Such as: ferrous sulfate or iron-dextrin.
It is small and easy-tolerated to take gastrointestinal reaction after the meal.Feeding cereal, newborn class and tea inhibits chalybeate to absorb, and fish, meat, vitamin C can
Reinforce chalybeate to absorb.Oral Iron Preparations effectively show peripheral blood ceticulocytosis before this, and peak is 5~10 after starting medication
It, hemoglobin concentration rises after 2 weeks, restores within general 2 months or so normal.Iron in treatment should be after hemoglobin restores normal
Continue 2~3 months, is discontinued after ferritin is normal.If Oral Iron Preparations are not resistant to or gastrointestinal tract normal anatomy position changes
Become and influence the absorption of iron, chalybeate intramuscular injection can be used.The prognosis of hypoferric anemia: simple subalimentation person easily restores normal;
Secondary to other diseases person, can be eradicated depending on protopathy.The prevention of hypoferric anemia: infant, teenager are focused on
With the nutrition and health care of women;To infant, rich iron-containing food, such as eggs, liver, spinach should be added early;To teenager, answer
Partial eclipse is corrected, periodically looks into, control parasitic infection;Chalybeate can be supplemented to pregnant woman, breast feeding women;The moon should be prevented and treated to menstrual period women
Through excessive.Carry out the crowd prevention and treatment of tumor disease and chronic hemorrhagic disease.
Insufficiency of vital energy and blood refers to the deficiency of vital energy and the deficiency of blood in traditional Chinese medicine.Chinese medicine thinks that " gas ", " blood " are to constitute and maintain human body raw
Movable base substance is ordered, spring is easy sleepiness just because of asthenia of qi and blood, and blood-nourishing, therefore the people of can just fostering the spirit of nobility that sleep
It is more snoozed than other seasons.The people of the deficiency of vital energy, is easy to produce feeling of fatigue, cannot adhere to work, and four limbs are usually out of strength.Chinese medicine is to qi and blood
Insufficient understanding: gas is to operate in a kind of intracorporal cereal nutrient of people.Energy with extremely strong energy, excitation and promotion machine
The functional activity of body organ, therefore also represent the gas of QI of five ZANG-organs and passages through which vital energy circulates.The effect of gas is mainly the feeding body of temperature and resists outer
Evil invasion, simultaneously participates in the metabolism of viscera function.Blood is the red liquid flowed in passages through which vital energy circulates.The function of blood has two sides
Face.First, raising internal organs body channels and collaterals and bone key.Blood is contained then shape and is good for, and flushing profit, skin smooth, hair are moist, joint is clever
It is living.Second, blood is the material base of cerebration.Blood contains then spirit and QI cleaning, resourceful.Blood deficiency is then absent-minded, the heart
Throb with fear uneasiness.The result of insufficiency of vital energy and blood will lead to the decline of viscera function, cause early ageing.The deficiency of vital energy, that is, viscera function decline disease resistance
Difference shows as aversion to cold and cold limbs, spontaneous perspiration, dizziness and tinnitus, apathetic, tired inability, shortness of breath and palpitation, hypoevolutism.The deficiency of blood is visible
Lusterless complexion is sallow, dry skin, hair are withered, nail is dry and cracked, blurring of vision, numb in every limb, insomnia and dreamful sleep, amnesia palpitaition,
It is absent-minded.Insufficiency of vital energy and blood category QI and blood being ill simultaneously.Deficiency of qi and blood then can body dystrophy, with spiritlessness and weakness, shortness of breath lazyness speech, pale white complexion
Or it is sallow, have a dizzy spell, lip and nail color is light, palpitation and insomnia, pale tongue weak pulse etc. are common syndrome.Common disease factor is: deficiency of QI causing insufficiency of blood,
Prolonged illness is felt frustrated hematozemia, and causes deficiency of qi and blood.Common sympton is: aversion to cold and cold limbs, spontaneous perspiration, dizziness and tinnitus, tired inability, palpitaition etc..
Qi and blood is the material base for safeguarding body normal function, and gas can push blood operation, and blood can deliver gas, and qi and blood is mutually grown
It is raw, the few then deficiency of vital energy of deficiency of QI causing insufficiency of blood, blood.Prolonged illness is felt frustrated hematozemia, and causes deficiency of qi and blood.The clinical manifestation of insufficiency of vital energy and blood is mainly,
Insufficiency of vital energy and blood has a delicate constitution, the deficiency of vital energy then aversion to cold and cold limbs, spontaneous perspiration, dizziness and tinnitus, tired inability, shortness of breath and palpitation, hypoevolutism.Blood
Empty visible lusterless complexion is sallow, dry skin, hair is withered, nail is dry and cracked, blurring of vision, numb in every limb, insomnia and dreamful sleep, amnesia
It is palpitaition, absent-minded.Insufficiency of vital energy and blood then spiritlessness and weakness, shortness of breath lazyness speech, pale white complexion or it is sallow, have a dizzy spell, lip and nail color is light, the heart
Insomnia, the feminine menstrual amount of throbbing with fear are few, delay or amenorrhoea, pale tongue weak pulse.The main symptom of deficiency of qi and blood: the few China of sallow complexion, deficiency of QI with disinclination to talk,
Fatigue and weakness is had a dizzy spell, and palpitation and sleeplessness, deficiency of food is indigestion and loss of appetite, pale tongue, soft and thready pulse.It can judge qi and blood not in terms of following
Foot: 1. eyes: the color and clarity of eyes, the color of the white of the eye become muddy, jaundice, have the trace of blood, show insufficiency of vital energy and blood.2. skin
Skin: skin is white inner pink, it is glossy, elastic, without wrinkle, without spot, the qi and blood for representing lung is sufficient.Pachylosis there is not gloss,
It shades, turn to be yellow, whitening, pastiness, rubescent, long spot, showing that physical condition is bad, insufficiency of vital energy and blood.3. hair: the speed of growth of hair
With liver blood correlation, if deficiency of liver-blood, hair grows slow, hair and dries up hair loss, and hair turns to be yellow, whitens, jag, shows qi and blood not
Foot, the decline of liver blood kidney qi.4. gum: gum is related to stomach and intestine, and gingival atrophy represents insufficiency of vital energy and blood.5. nail: not having on finger
There is semilune on semilune or only thumb, longitudinal grin occur on nail, illustrates internal cold air weight, qi-blood deficiency, overdraw,
It is the symbol of senility of humanbody.6. finger: finger pulp loss is full, and how flexible meat is, illustrates qi and blood abundance;Finger pulp loss is flat, thin
Weak or finger tip is fine, then represents insufficiency of vital energy and blood.7. sleeping: falling asleep, fast, sleep is heavy, eupnea, and a feel wakes up naturally, and says
Bright qi and blood foot;Difficulty falling asleep, easily frightened easily to wake up, frequent urination at night breathes very grave or snores, shows deficiency of qi and blood.8. movement: when movement
Occur uncomfortable in chest, shortness of breath, fatigue be difficult to the state restored, then show insufficiency of vital energy and blood.9. the temperature of hand: qi and blood abundance hand is warm
's;It is all the performance of insufficiency of vital energy and blood if palm of the hand partial heat or perspiration or hand are cold.Briefly, insufficiency of vital energy and blood, the deficiency of vital energy embody
It is nervous for movement asthma, movement, and the deficiency of blood is presented as that complexion turns to be yellow, whitens, giddy is nervous, feel not sleep well.
Aging, refer to body the physiology and psychological fitness progressive of environment are reduced, gradually phenomenon deathward.It declines
Two classes: physiological aging and pathological seaility can be divided into always.The former refers to the physiological degenerative process occurred after the maturity period, Hou Zheshi
The senile variation caused by various foeign elements (including various diseases).The two is practical to be difficult to distinguish.In short, aging is
The inevitable outcome of many pathology, physiology and noematic comprehensive function is the biology heart of individual growth development final stage
Electrophysiologic procedure.Said from biologically, aging be biology over time, spontaneous necessary process, it is complicated nature
Phenomenon shows as the decline of the degeneration variation and function of structure, adaptability and resistance decline.In a physiologically, aging
Regard as and is performed until old ontogeny since fertilized eggs.From pathology, aging is stress and to strain, damage
And infection, immune response decline, trophic disturbance, the result that dysbolism and carelessness and drug abuse accumulate.In addition from society
It is seen on, aging is that individual loses interest to fangle, detaches oneself from reality, likes missing old times or old friends.Occur with life, in development process
A kind of activity, be body from the forfeiture and degenerative process for constituting substance, institutional framework to physiological function.Aging course be from by
To what is persistently occurred between death, the feature for only having arrived certain stage aging just displays smart ovum obviously.People
Physiological change in body aging course is mainly reflected in body tissue cell and constitutes the forfeiture of substance, and organism metabolism rate subtracts
It is slow, body and decreased organ function.Aging is inevitable, but it is possible for delaying senescence.Reasonable diet, balanced nutrients
It is one of anti-aging, the important measures for extending the service life.The major physiological performance of aging is: (1) metamorphosis.It include: 1. thin
Born of the same parents' variation.It is mainly shown as gradually reducing for cell number.2. the variation of tissue and organ.Due to the cell of internal organs and tissue
Quantity is reduced, so that atrophy, weight saving occur.3. overall variation.With advancing age, the bodily form and shape change,
As hair bleaches;Skin elasticity reduces, and wrinkle occurs, senile plaque occurs;Tooth mobility falls off, deafness, dim eyesight, hunchback, height
It is gradually shortened.(2) physiological function declines.It include: the decline of 1. systema cariovasculare functional.Such as cardiac muscle fibre gradually atrophy, the heart
Age pigment (lipofuscin) deposits in myocyte, and heart valve becomes plump hardening, elasticity reduces etc..2. respiratory apparatus aging.Table
It is now reduced for lung volume, respiratory function obviously declines, and compensatory capacity reduces.3. the variation of digestive system.Mainly oral cavity, stomach and intestine
Atrophic variation occurs for miopragia, gum, tooth.4. muscle skeleton kinematic system changes.It is mainly manifested in and increases with the age,
Muscle fibre attenuates, elasticity reduces, convergent force weakens;Organic component is reduced in bone, and inorganic salts increase, thus cause the elasticity of bone
Toughness reduce, easily fracture etc..5. nervous system changes.It is mainly shown as the forfeiture to a certain degree of brain cell;Nerve conduction
Speed reduces;The slow movement of the elderly, reflection flexibility decrease etc..(3) primary sensing organ's hypofunction.Such as vision is listened
Feel, smell, the sense of taste, dermal sensation (including tactile, the sense of heat, pain sensation) decline.In addition, the elderly's psychokinesis reflects also phase
It is slow to answer.Aging itself has 6 big characteristics, 1. generality: i.e. aging can all occur for all living things body.2. internality: aging course
It is necessary process spontaneous in organism, is that live in optimum environment also can gradually aging.3. progressive: aging is
The process continued to develop over time.4. harmfulness: aging reduces the physiological function of organism, increases sick
With dead chance.5. individual difference: in same class biology, the process of aging is different between Different Individual, is especially existed
The later period of life, this otherness become apparent.Only the slower individual of those agings is possible to obtain long-lived.6. may interfere with
Property: although aging is inherent spontaneous process, but external condition can accelerate or delay the progress of this process.Such as environment temperature
It can change the service life of animal.Just because of this, people are possible to seek longevity by bettering people's living environment.Angle of physiology
It sees, aging is as caused by metabolism decline.Metabolism is one of essential characteristic of vital movement, it includes synthesis generation
It thanks and two aspect of catabolism.If the anabolism of body be higher than catabolism, people will growth and development, here it is boyhoods
And the adolescence;If the speed of the two metabolic processes is in a basic balance, people has arrived midlife and mature stage, this period human body
Variation it is smaller;If catabolism is higher than anabolism, people begins to aging, if metabolism once stops, the life of people
Life activity also just finishes.People in life, above-mentioned variation is generally existing, therefore aging is inevitable.But
People in life, due to inherent or external, occur that aging course ahead of time, here it is early ageing.Early ageing is that pathology is old
Change, it will affect the service life of people.Although people is easy to happen pathologic aging to the senescence phase, but not everyone must will send out
It is raw.Therefore physiological aging to be inevitable the natural law, and what pathologic aging then can be prevented from and postpone.In order to same
Aging is waged a struggle, and people once conducted extensive research the mechanism of aging.But up to now in relation to causing the machine of aging
System not yet satisfies oneself.Briefly, the apparent external embodiment of aging is: poor physical capacity, easily insomnia, Hearing, taste weigh,
High blood pressure, alopecia etc..
Immune is a kind of protectiveness physiological reaction of body, by immune function to maintain the balance of vivo environment and steady
It is fixed, and then there is immunity disease in immunologic dysfunction.Scientist's research is immunized according to the U.S., mankind's major part disease is attributed to exempt from
Epidemic disease system goes wrong.Long-term stress has an important influence the immune function of human body, Thelma Hopkins medical college of the U.S.
Professor Thomas the observation up to 18 years has been carried out to 1337 volunteers, have been found that people is chronically at lonely, contradiction, mistake
It hopes, constrain state, just will affect the balance of vivo environment, so that resistance weakens.City now is lived in, everyone is strong
Health is all easy to be on the hazard, including air pollution, drinking water pollution, environmental pollution, operating pressure, economic pressures, improper diet, thin
Bacterium virus etc., the factor of all these unfavorable health, can cause immunity of organisms low, and being usually expressed as people's spirit cannot collect
In, memory loss, frequent burnout, susceptible disease, aging etc. ahead of time.It is more especially the crowd of occupation with mental labour,
Opposite stress is very big, so that stress is put aside for a long time, brain overload operation, and so that immunity degradation is caused, it is muddy
Body is powerless, and dizzy eye is puckery, shortness of breath and palpitation, insomnia forgetfulness etc..Immunocompromised person, easily catches a cold and epidemic disease, and permanent immunity
The low person of power is easy to infect than healthy population, and any reason causes compromised immune, then bacterium, virus etc. will gather in vivo
Collection, and cause human body sick.The intracorporal immune system of people is the best weapons of system, has the infringement for resisting pathogenic microorganism
The effects of.Immune a kind of biological answer-reply process as " identification " and " exclusion " non-antigen, to maintain intracorporal physiology flat
Weighing apparatus.Immunity function is the basis of human health, immune dysfunction and it is low when, the ability of body fight infections can be reduced,
It reduces identification and removes the histocyte ability of itself aging, reduce killing and remove the ability of abnormal sudden change cell in vivo,
Lead to the decline of human body premunition and vis medicatrix naturae.And modern society, the accelerating rhythm of life, the increase of competitive pressure make many
People is in nervous working and learning state, and body, which is chronically at this tense situation, will inhibit immune function;Meanwhile it is nervous
Working and learning allow more people to have to convenient fast food, the unbalance of endotrophic element is caused, if body is located for a long time
In this state, immunity of organisms can be made to decline, eventually lead to the sub-health state of body.
Microcirculation in human body is the direct circulation for participating in cell, the body fluid (blood, lymph, tissue fluid) that suck tissue exchanges
Dynamically.Blood is flowing, circulation, and the most fundamental function of blood circulation is that the substance carried out between blood and tissue is handed over
It changes, this function is exactly to realize in microcirculation.So microcirculation is an important component of systemic blood circulation, it is raw
The basic link of life, be body and ambient enviroment constantly carry out substance, energy, information exchange process.The blood of human body by
After heart pumps out, through main artery to parteriole to arteriole, capillary is entered back into, then by venule and venous return at different levels
To heart.This blood circulation between arteriole and venule is known as microcirculation.Medically, microcirculation further includes lymph
The microcirculation of liquid and tissue fluid, but usually said microcirculation refers to blood microcirculation.There are four features for the structure of microcirculation, micro-
Circulation is longest, most thin, most thin, most slow thin vessels, the supply system throughout whole body weaved into.It is thin: arteriole and micro- quiet
Vascular diameter is very thin, only the 1/20 of hairline, only 1-2 red blood cell is allowed to pass through;Thin: arteriole and venule tube wall are very thin,
Only the 1/100 of a piece of paper affects between histocyte once tube wall thickening to carry out mass exchange with histocyte
Mass exchange;Long: the arteriole of a normal person is added up with venule, can enclose half around the earth two;It is slow: arteriole and micro- quiet
Blood flow velocity in arteries and veins is very slow, and 1 mm/second of flow velocity, when blood viscosity increases, blood flow velocity is slower, and blood content is held
It is easily deposited on vascular wall, forms embolism, occluding vascular.The major function of microcirculation is the substance realized between blood and histocyte
Nutriment (including nutriment and oxygen) discharge waste (including metabolite and carbon dioxide) is transported in exchange.The blood of microcirculation
Manage most thin, it is the real nutrient vessel of histocyte that tube wall is most thin, blood flow optimum, and capilary can allow oxygen and dioxy
Change carbon to pass through;Glucose, amino acid can be allowed to pass through;Salt water and other nutriments can be allowed to pass through.Capilary provides substance
The clearing house of metabolism completes material exchange process by microcirculation.Thus it is guaranteed that body tissue's cell is normal new old
Metabolism, maintains the vital functions of physical activity.In short, microcirculation is the base of body growth and development, it can be more in variation
In the organism metabolism active mechanism at end, adjustment effect is played by perfused tissue, guarantees the balance of interior environment.Microcirculation normally with
No is the important symbol of human health status.Microcirculation is that human tissue cell absorbs nutrition, oxygen, and the friendship of metabolite is discharged
Carry over institute.Human body leans on merely the contraction power of heart that blood cannot be directly filled into the histocyte of each organ of human body, it is necessary to
The spontaneous vasomotion synchronous with heartbeat does not fill second of adjusting of blood progress to capillary by microcirculation part for the second time
Note, so medically microcirculation is likened to " the second heart " of human body.The function of microcirculation mainly has three aspects: substance is handed over
The place changed, blood ship oxygen, nutriment, hormone and water etc. to tissue, take away carbon dioxide and metabolite.Microcirculation
It is unique place that these substances swap;Each histocyte of connection whole body;Regulating blood flow and blood volume, the blood vessel number of microcirculation
Amount is extremely more, capacity is very big, is a big blood reservoir.Change the appearance blood volume of this blood bank, so that it may adjust the circulating blood volume of whole body
With the returned blood volume of vein.Once systemic microcirculation blood vessel is caused largely to open for some reason, there will be a large amount of sludgings to exist
In microcirculation, circulating blood volume and returned blood volume is caused to reduce, blood pressure decline.If corrected not in time, serious consequence will be caused.
Microcirculation disorder is common in the middle-aged and the old, and when obstacle occurs for microcirculation, the blood vessel distortion of microcirculation stops up in blood vessel, by
This caused organ-tissue, cell ischemic, hypoxic cell necrosis, lesion.The unimpeded all kinds of diseases and ailments of microcirculation are not given birth to, and micro- obstacle that follows is hundred
The source of disease.Since our capillary is very long, often have impurity muddiness in blood, as cholesterol, alcohol, nicotine,
Drug residue, chemical residue etc., they not only make vascular wall thicken, and are frequently occluded blood vessel sometimes, cause blood operation not
Freely, such systemic cell cannot be metabolized in time causes cell function to weaken, and over time, just produces disease.Microcirculation can
Using the primary or secondary responsive organs as many pathologic processes and disease, to microcirculation disorder occur.Microcirculation disorder
The function or organic disorder that capilary and micro- blood flow levels occur are referred mainly to, to cause the obstacle of Microcirculation perfusion.
Microcirculation disorder finally makes Blood cell accumulation, and slow blood flow, pachyemia, blood viscosity increases and thrombus easy to form, or tissue
Cell ischemic, anoxic and lesion occurs.Usual microcirculation disorder is unconsciously to generate, it is possible in the quite a while
Interior non-evident sympton and be in incubation period, have now been found that the means that predominantly detect of microcirculation disorder are aobvious by computer microcirculation
Micro- television system makees somatoscopy, it be general X-ray, electrocardiogram, B ultrasound institute it is irreplaceable.
Ovary dissects name.It is pairs of parenchymatous organ in female pelvic cavity.Belong to female gonad, be in flat oval,
Divide inside and outside side, front and rear edges and upper and lower end.Lateral surface is affixed on pelvic side wall, the folder between Internal and external iliac arteries initial part
At angle, medial surface is towards uterus;Upper end borrows ligamentum suspensorium ovarii to be connected with pelvic cavity wall, and lower end borrows ovarian proper ligament to be connected in uterus;
Rear is free, and leading edge has mesentery attachment, and has blood vessel, lymphatic vessel and nerve to enter and leave.Its size and shape increase with the age and are had
Change: youngest daughter's phase, surface are smooth;After puberty, due to repeatedly ovulating, surface forms scar, uneven;Sexual maturing period ovary
Maximum, long 2.5~5.0cm, wide 1.5~3.0cm, 0.6~1.5cm of thickness.Post menopausal, volume are substantially reduced, and in elderly woman,
Its length and width, thickness all only have 0.5cm or so.Its major function is to generate and be discharged egg cell, is secreted sex hormones, to promote female
The development of property sex character simultaneously maintains it.In general, a mature egg is monthly alternately discharged in left and right ovary.
Ovarian function is bad to will affect female hormone secretion and sexual function, skin quality, the colour of skin and women measurements of the chest, waist and hips posture, makes face
Jaundice, posture is too fat to move, and vagina is dry, enters into the climacteric period ahead of time, i.e. aging is arrived.35-45 years old ovaries are reached when the age of women
Start to be gradually reduced, to after menopause, ovary can taper into the 1/2 of original volume.Since ovary is repeatedly ovulated, ovarian follicle is broken
Atrophy is split, is replaced by connective tissue, essence is hardened gradually.So female friends in terms of living habit, will adhere to often drinking
Milk, intake fish, the foods such as shrimp, often takes exercises, builds up health, it is important to note that in public places, that family is reduced is passive
Smoking, so that early menopause be avoided to endanger to women's health bring.Ovary maintaining must be got well, and skin of face can be made moist,
It is white touched with red, maintain toughness and elasticity;Promote reproduction and body health, adjust and secrete female sex hormone, improves two sexual lifves
Quality;Chest is plentiful, consolidation, mellow and full.
With the continuous variation of rhythm of life and social environment, more and more women are premature to there is ovarian function not
It is good so that many 30 years old less than women there have been premature ovarian failures the phenomenon that, this for the women not given birth to,
A undoubtedly heavy strike.Exactly because such reality needs to carry out potentially hazardous factor prevention early, with
Reduce the generation of ovarian function aging.Whether female ovary function can normally be understood with reference to following index: first is that ovary
Ovulation function.Many women occur as soon as that ovarian follicle function is bad when youth, are mainly manifested in excessive ovulation every month
Either very few ovulation.When number of eggs ovulated every month increases, women can be caused menstruation occur abnormal, thereby result in phase
" polycystic ovary syndrome " answered occurs, this makes the blood glucose of women, blood pressure etc. cause to change, and also results in the infertile machine of women
Rate increases.So it is highly important for being taken when menstruation is bad to the monitoring of ovarian follicle, especially for the women for having menstruation
It is the presence of abnormal women for Follicle number, it should it goes after hospital's consulting to take treatment, in order to avoid cause child-bearing period infertile
Symptom occurs.Second is that the level of sex hormone, the relevant hormone of general inspection female ovary function has 6, they respectively with ovary
Secretion exist be closely connected.This 6 kinds of hormones are Folliculogenesis hormone, luteotropic hormone, estradiol, progesterone, testosterone respectively
And lactogen, they can substantially cover the function in terms of ovarian secretion, therefore pass through the inspection to this 6 kinds of hormones, base
Can have to ovary on this and substantially understand.Third is that the report of B ultrasound is as a result, the result not only can reflect out the appearance of ovary, and
And also with the clear tumour whether having in terms of ovary, especially gynecopathy, malignant cysts etc. relatively common at present, these tumours
Appearance the function of ovary can also be caused to go wrong, therefore be also required to be checked one by one using B ultrasound.Ovary is carried out
The inspection of B ultrasound in addition, having also been found that other tumours by B ultrasound needs that modus operandi is taken to be treated when necessary,
Also including drug therapy etc..
Premature ovarian failure, which refers to women once, the natural menstrual cycle, and occurs ovarian atrophy before 45 years old through measuring
It reduces, menstrual period shorten, and the menstrual cycle increases, until continuing amenorrhoea.The cause of disease may be infection, iatrogenic premature ovarian failure, idiopathic
Premature ovarian failure and immune factor etc..Meanwhile clinical signs secondary sex characters is shunk back, occur face warm, be vexed, the climacteric such as irritability
Phase symptom;Usually easy catching a cold, blood follicular stimulating hormone level increases, and up to more than 40 units, is equivalent to postmenopausal women's level;And blood
Estradiol level is significantly low.The obvious atrophy of gynecologial examination internal genitalia, vagina mucosa are thin and congested.It cuts open the belly and makees ovary living tissue
It checks, it is seen that ovarian atrophy is shown in be fibr tissue in ovary cortex under microscope, and the folliculus at different levels such as no primordium folliculus are visible.
The cause of disease of premature ovarian failure includes following aspect, 1. infection: viral such as herpes simplex virus, mumps virus
Ovary inflammation or immunity ovary can be caused, which to damage, leads to premature ovarian failure.The decline of ovarian function is a gradual process, big absolutely
Most of patients shows as infrequent menstruation or paramenia before there is premature ovarian failure, may occur in which hectic fever, perspiration, vexed, amnesia etc.
Climacteric performance.The obvious aging of women, dry skin, and easily merge osteoporosis.2. iatrogenic premature ovarian failure.Before 40 years old
Excision bilateral or side ovary can cause the decline of the function of organization such as ovary to lead to premature ovarian failure.It is considered that excision side ovary
Afterwards, opposite side ovary can maintain normal endocrine function.In recent years the study found that side ovary excision after, ovarian secretion
The chance that hormone decline, osteoporosis and menopause symptom occur increases.In addition, invasive surgical should be avoided to operate as far as possible,
Such as repeated multiple times induced abortion.3. idiopathic premature ovarian failure.It is a kind of secondary amenorrhea without clear pathogenic factor, is ovum
The most important type of nest early ageing.It mostly falls ill in the childbearing age, gradual or progressive infrequent menstruation, then amenorrhoea clinically occurs
And with menopause symptoms such as hectic fever, agitations, inside and outside reproductive organs is in atrophing state.4. immune factor: most immunity diseases
The combinable premature ovarian failure of such as thyroiditis.Premature ovarian failure is commonly considered as autoimmune disease, it may be possible to which virus infection is drawn
Immunity oaritis of the body risen to itself ovary tissue.All and autoimmune phenomena is seen caused by all immunity diseases, or
The disease for existing simultaneously more than one finds expression in polyadenous body exhaustion syndrome.Due to existing in the serum of ovarian autoimmunity person
A kind of anti-ovarian antibodies, thus the visible lymphocytic infiltration of ovarian biopsy.Have and is caused due to operation, radiotherapy influence ovary blood fortune.
Have and is caused because ovarian follicle is congenital very few or gonadotropic hormone overstimulation accelerates follicle atresia.5. the infertile rate of modern mentions
It rises, some women are forced to promote the probability of pregnancy with the method for ovulation induction, but this way is if excessively, killed ovary
Overstrain is very big.6. excessive weight-reducing, causes body fat to drastically reduce, just will affect when fat ratio is too low female in vivo
The level of hormone, because the primary raw material of synthetic estrogen is fat, body fat is insufficient, causes estrogen at deficiency, female to swash
Element, which is reduced, can cause paramenia again, or even amenorrhoea occurs, and improper amenorrhoea can inhibit the ovulation function of ovary, be easy to make
At premature ovarian failure, if treatment is not in time, or even will cause infertile.Premature ovarian failure can aggravate paramenia again, be thusly-formed
Vicious circle.7. modern women is in keen competition, since stress is excessive, it can if things go on like this cause vegetative nerve
Dysfunction influences human endocrine adjusting, so that ovarian function fails too early, the secretion of estrogen is reduced, and mentions climacteric
Preceding arrival.8. the undesirable living habit such as smoke and drink also results in premature ovarian failure, because in the nicotine and wine in cigarette
Alcohol interferes normal menstruation and leads to paramenia.Clinic is significantly increased according to amenorrhoea, blood FSH, LH, blood E2 extreme bottom fall and
Ovary tissue biopsy can make a definite diagnosis without primordial follicle.The clinical manifestation of premature ovarian failure mainly has following aspect, and 1. premature ovarian failures are suffered from
Person is easy to happen gonad development secondary infertility, and menstruation is gradually rare until amenorrhoea after the several years.2. chain reaction in patients with premature ovarian is easy to cause
The non-development person of sexual gland, primary amenorrhea, gonadal agenesis person's first menses delay or irregular menses, dysmenorrhea.3. chain reaction in patients with premature ovarian
It is easy to cause mastatrophy sagging, cutis laxa is coarse, and nervous, dreaminess is suspicious, palpitaition, osteoporosis, arthralgia, genitals
Official's inflammation, metroptosis, the urinary incontinence, constipation, small pox, color spot.It does not ovulate 4. chain reaction in patients with premature ovarian is easy to cause, there is ovulation person,
Typical POF has hectic fever, and hypogonadism shows, such as night sweat, constipation, alopecia, colpoxerosis, sexual life pain, sexual desire decline,
Hypothyroidism, urinary infection, weight gain, anxiety are suspicious etc..
According to above-mentioned, by improving female ovary function, and then female skin can be improved.Such as face's jaundice, skin
Dry, cutis laxa is coarse etc..
The present invention is by largely testing, it was confirmed that technical solution of the present invention presents one or more unexpected beneficial
Effect.
Specific embodiment
The present invention can be further described by the following examples, however, the scope of the present invention and unlimited
In following embodiments.One of skill in the art, can be with it is understood that under the premise of without departing substantially from the spirit and scope of the present invention
Various change and modification are carried out to the present invention.The present invention carries out the material and test method arrived used in test general
And/or specific description.Although to realize the present invention many materials and operating method used in purpose be it is known in the art that
But the present invention is still described in this detail as much as possible.When preparing composition, prescription is indicated with parts by weight below, and every batch of is total
At least 10 kilograms of inventory, when specific dosage form is made, each unit formulation contains X-factor 100mg.
Embodiment 1: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (starch): 300 parts by weight,
Phosphatide (soybean): 7.5 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 22% solution;Phospholipid solution is sprayed in stream in 33 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 25 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -18 DEG C to freeze 28 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (capsule) should be made in fine-powdered composition in half amount.
Embodiment 2: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (sucrose): 100 parts by weight,
Phosphatide (soybean): 25 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 20% solution;Phospholipid solution is sprayed in stream in 35 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 30 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -20 DEG C to freeze 24 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (tablet) should be made in fine-powdered composition in half amount.
Embodiment 3: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (lactose): 1000 parts by weight,
Phosphatide (soybean): 1 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 25% solution;Phospholipid solution is sprayed in stream in 30 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 20 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -15 DEG C to freeze 30 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (soft capsule) should be made in fine-powdered composition in half amount.
Embodiment 4: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (microcrystalline cellulose): 750 parts by weight,
Phosphatide (yolk): 5 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 21% solution;Phospholipid solution is sprayed in stream in 34 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 22 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -19 DEG C to freeze 25 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (granule) should be made in fine-powdered composition in half amount.
Embodiment 5: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (calcium monohydrogen phosphate): 100 parts by weight,
Phosphatide (yolk): 15 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 24% solution;Phospholipid solution is sprayed in stream in 31 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 28 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -16 DEG C to freeze 29 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (dry suspensoid agent) should be made in fine-powdered composition in half amount.
Embodiment 6: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (starch): 100 parts by weight,
Phosphatide (soybean): 5 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 22% solution;Phospholipid solution is sprayed in stream in 33 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 24 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -17 DEG C to freeze 26 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (tablet) should be made in fine-powdered composition in half amount.
Embodiment 7: composition is prepared
Prescription:
X-factor: 100 parts by weight,
Diluent (starch): 500 parts by weight,
Phosphatide (soybean): 10 parts by weight.
Preparation method: X-factor is made to be crushed to the fine powder that can pass through 100 mesh screens in advance;Phosphatide is set to be dissolved in ethyl alcohol
In be made concentration be 23% solution;Phospholipid solution is sprayed in stream in 32 DEG C of fluidizing equipments (fluidised bed granulator)
In the X-factor fine powder of change state, continues fluidisation and remove ethyl alcohol;The diluent that 26 parts by weight are added is uniformly mixed, and is used
Material is compressed into tablet form object by extruder;This tablet is set -18 DEG C to freeze 28 hours;Tablet is crushed, it is dilute that surplus is added
It releases agent to be mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;
Further, dosage form (capsule) should be made in fine-powdered composition in half amount.
Embodiment 8: composition is prepared
Reference implementation example 1~7, different is prepared and (does not freeze) according to following method: keeping X-factor preparatory
It is crushed to the fine powder that can pass through 100 mesh screens;Phosphatide is set to be dissolved in the solution that respective concentration is made in ethyl alcohol;In relevant temperature
Phospholipid solution is sprayed in the X-factor fine powder in fluidized state in fluidizing equipment (fluidised bed granulator), after
Ethyl alcohol is eliminated in afterflow;The diluent that corresponding amount is added is uniformly mixed, and material is compressed into tablet form object with extruder;By tablet
It is broken, balance diluents are added and are mixed, composition can be obtained by the fine powder of 60 meshes by continuing to be crushed to;Further, by one
Corresponding dosage form should be made in fine-powdered composition in half amount.7 kinds of compositions and preparation is made.
Embodiment 9: composition is prepared
Reference implementation example 1~7, different is only to prepare (not tabletting) according to following method: keeping X-factor preparatory
It is crushed to the fine powder that can pass through 100 mesh screens;Phosphatide is set to be dissolved in the solution that respective concentration is made in ethyl alcohol;In relevant temperature
Phospholipid solution is sprayed in the X-factor fine powder in fluidized state in fluidizing equipment (fluidised bed granulator), after
Ethyl alcohol is eliminated in afterflow;The diluent that corresponding amount is added is uniformly mixed, this mixture is set and freezes the corresponding time under relevant temperature;
Balance diluents are added to be mixed, obtain composition;Further, corresponding system should be made in fine-powdered composition in half amount
Dosage form formula.7 kinds of compositions and preparation is made.
Embodiment 10: composition is prepared
Reference implementation example 1~7, the difference is that phosphatide is not added and prepares according to following method and (phosphatide is not added): making chlorination height
Iron ferroheme is crushed to the fine powder that can pass through 100 mesh screens in advance;In fluidizing equipment (such as the fluidized bed granulation of relevant temperature
Machine) in ethanol solution is sprayed in the X-factor fine powder in fluidized state, continue fluidisation remove ethyl alcohol (with reality
As applying example 1~7, powder can tie grain);The diluent that corresponding amount is added is uniformly mixed, and is compressed into tablet form material with extruder
Object;This tablet is set and freezes the corresponding time under relevant temperature;Tablet is crushed, balance diluents are added and are mixed, after continued powder
Composition can be obtained by the fine powder of 60 meshes by being broken to;Further, should be made half amount accordingly in fine-powdered composition
Dosage form.7 kinds of compositions and preparation is made.7 kinds of compositions and preparation is made.
Test example 1: X-factor composition treats hypoferric anemia
1, subject: according to the clinical criteria hemoglobin (Hb) of hypoferric anemia, male < 120g/L, women <
110g/L;Red blood cell (RBC), male < 400 × 1010/ L, women < 350 × 1010/L;Serum ferritin (SF), male < 15 μ g/
L, women < 12 μ g/L;Serum levels of iron (SI) < 11 μm ol/L;Total iron binding capacity (TIBC) > 64 μm ol/L;Wherein SF is to iron deficiency and iron
Developing agent storage amount is excessive etc. larger value.The present invention 38 Anemic patients of selection, male 5, women 33, the age 17~61
In year, average age 48.2 years old, all patients were not cured through Ferrous Sulphate for Treatment;It is examined through inquiry medical history, physique before medication
It looks into and hematological system is chemically examined.
2, blood examination method: hemoglobin photoelectricity colorimetric method for determining, red blood cell is to count measurement, serum levels of iron, iron egg
White, total iron binding capacity is measured with enzyme linked immunosorbent assay.
3, dosage and the course for the treatment of:, dividing 3 times and take orally by daily 3 grams in terms of X-factor of dosage, and 1 month is as a treatment course,
All patients take a course for the treatment of.Object is closed with example 1 group to be treated.
4, efficacy determination: point effective, woman turns, is invalid.Effective: clinical symptoms are obviously improved (dizzy, disappearance out of strength, complexion
It is ruddy), 5 physiochemical indices at least 4 have it is larger improve (hemoglobin increase 20g/L or more, red blood cell count(RBC) increase by 50 ×
1010/ L or more, ferritin increase by 10 μ g/L or more, serum levels of iron increase by 4 μm of ol/L or more, total iron binding capacity reduce 10 μm of ol/L with
On);Improve: clinical symptoms improve, and 5 physiochemical indices at least 2 have larger improvement, and other several also make moderate progress;It is invalid:
Effective and improvement standard person is not achieved to be included in vain.
5, result: all patients are taken medicine the comparison of forward and backward subjective symptoms: there is dizzy person 33 before medication, person 36 out of strength,
Pale complexion person 21, receive poor person 16;There is dizzy person 1 after treatment, person 2 out of strength, pale complexion person 0, receives poor person 0
Example.Items physiochemical indice average value, which compares (mean value ± SD, n=38), before and after treatment see the table below:
Index | Anaemia standard | Before medication | After medication | Equal value difference | P value |
Hemoglobin, Hb (g/L) | < 120 or < 110 | 88.2±10.7 | 119.4±10.7 | 31.2 | <0.001 |
Red blood cell, RBC (1010/L) | < 400 or < 350 | 292±33 | 413±51 | 121 | <0.001 |
Serum ferritin, SF (μ g/L) | < 15 or < 12 | 9.2±1.3 | 16.4±3.8 | 7.2 | <0.001 |
Serum levels of iron, SI (μm ol/L) | <11 | 8.6±2.2 | 14.1±2.6 | 5.5 | <0.001 |
Total iron binding capacity, TIBC (mol/L) | >64 | 73±14 | 52±9 | -21 | <0.001 |
Wherein, p value is that each index treats forward and backward comparison, there is statistically-significant difference.
According to curative effect determinate standard statistics above, effective 29 people, accounting 76.3%;Improve 8 people, accounting 21.1%;Nothing
Imitate 1 people, accounting 2.6%;There is 14 people recovery from illness in effective person, clinical symptoms disappear and 5 physiochemical indices reach normal value.
Whole receptors are showed no gastrointestinal reaction, do not influence normal diet.
Test example 2: the pharmacodynamic study of X-factor composition treatment anaemia
For the anti-anemia action effect for understanding hemin, the method that we use hypoferric anemia combination blood loss anemia
Anemia in rats model is established, then to Anemia in Rats orally administration hemin aqueous solution.Hemoglobin is surveyed in experiment front and back
(Hb), hematocrit (Hct) and Erythrocyte chemokine recepter (FEP).Method is as follows:
1, materials and methods: animal is SD male rat, 110~130g of weight;Animal feeding is recommended low iron-based with AOAC
Plinth feed [Williama S.Official method of analysis of the association of official
Analytical chemists [M] .14th Edition, USA, 1984:880], which is 8ppm.
2, sample and grouping: embodiment 1,6,7 and embodiment 8,9 respectively refer to 1 method resulting composition of embodiment, altogether
5 kinds of mixture of powders, another group is fed with deionized water, as control.
3, method: rat is raised in iron-free environment with low iron base feed, while every animal bloodletting every other day 25 is dripped.To
When animal mean hemoglobin concentration drops to 80g/L or so within 3 weeks, the hemoglobin of rat is measured, dissociate in red blood cell former porphin
Quinoline is simultaneously weighed, and model foundation finishes.60 Anemia in Rats are randomly divided into 6 groups, every group 10 by hemoglobin concentration and weight
Only, 5 kinds of composition sample stomach-fillings (each group dosage is calculated as 5mg/kg weight with iron) is awarded respectively, one time a day.Simultaneously set from
Sub- water negative control group, each group rat continue to be fed with low iron feed, drink deionized water.The equal single cage raising of each group rat, test
In weigh within every 5 days, take tail hematometry hemoglobin concentration.After 4 weeks, when control group Hb restores to 95g/L, rat is measured
Hb, Hct, FEP.
4, result
Groups of animals, test before weight within the scope of 225~230g, after test weight within the scope of 290~305g,
Test front and back changes equal no difference of science of statistics between each group.
Each group Hb is in 84~86 (g/L) ranges before testing;After each group test compared with before test, control group Hb increases
Value is 9.7%, and 1,6,7 group of Hb value added of embodiment is in 33~36% ranges, and 8,9 groups of Hb value addeds of embodiment are 22~23%
In range and substantially less than 1,6,7 group of embodiment.
Each group Hct is in 29~31% ranges before testing;After each group test compared with before test, control group Hct increases
Value is 12.6%, 1,6,7 group of Hct value added of embodiment in 31~33% ranges, 8,9 groups of Hct value addeds of embodiment 19~
In 20% range and substantially less than 1,6,7 group of embodiment.
Each group FEP is within the scope of 14~15mg/L before testing;After each group test compared with before test, under control group FEP
Drop rate is 22.5%, and 1,6,7 group of FEP rate of descent of embodiment is in 39~41% ranges, and 8,9 groups of FEP rates of descent of embodiment are 31
In~32% range.
The above results show caused by act on to hemin for corresponding physiologic index, embodiment 1,
6, the significant effect of 7 compositions is better than embodiment 8, the effect of 9 compositions.
Test example 3: X-factor composition dissolubility is investigated
Various powder compositions or bulk pharmaceutical chemicals are filled into Capsules, every is calculated as with hemin
100mg, on dissolution test system, according to the of " Chinese Pharmacopoeia " version four in 2015 " 0931 dissolution rate and drug release determination method "
Two methods, that is, paddle method, dissolving medium 500ml put into a capsule in each stripping rotor, stir 1 hour at 37 DEG C, take solution, mistake
Filter measures trap at 400nm wavelength;Hemin reference substance separately is taken, is dissolved and is diluted with ethyl alcohol reference substance is made
Solution measures trap at 400nm wavelength, and then calculates the meltage of hemin in stripping rotor, with every capsule
In theoretical hemin amount calculate hemin dissolved fraction.
As a result: when dissolving medium is water, the dissolved fraction of bulk pharmaceutical chemicals is 12.3%, all combinations of 8~10 gained of embodiment
The dissolved fraction of object is in 11~14% ranges, and the dissolved fraction of all compositions obtained by Examples 1 to 7 is in 43~47% ranges
It is interior;When dissolving medium is 0.1M hydrochloric acid solution, the dissolved fraction of bulk pharmaceutical chemicals is 14.4%, the whole groups of 8~10 gained of embodiment
The dissolved fraction of object is closed in 15~17% ranges, the dissolved fraction of all compositions obtained by Examples 1 to 7 is in 54~59% models
In enclosing;When dissolving medium is 0.1M sodium hydroxide solution, the dissolved fraction of bulk pharmaceutical chemicals is 13.1%, 8~10 gained of embodiment
The dissolved fraction of all compositions in 15~18% ranges, the dissolved fraction of all compositions obtained by Examples 1 to 7 51~
In 53% range.As it can be seen that composition obtained has significantly superior solubility property by the method for the invention, this is the above results
The efficient absorption of present composition iron provides ample evidence.
Test example 4: improve the effect expedition of energy and blood of human body function delaying human body caducity
As mentioned in this article, the deficiency of vital energy is presented as that movement asthma, movement are nervous, and the deficiency of blood be presented as complexion turn to be yellow, whiten, head
Confused nervous, feel not sleep well;And the apparent external embodiment of aging is: poor physical capacity, easily insomnia, Hearing, taste weight, high blood pressure,
Alopecia etc..This test 1 gained capsule of the embodiment of the present invention improves energy and blood of human body function delaying human body to the present composition
The effect of aging is investigated.
It is included in subject 268 of test, male 76, women 192, the age 36~62 years old, 1 before on-test
During a month continues, evaluation is combined by observation, inquiry, private prosecution, have in this 268 subjects deficiency of vital energy shower be 184 people,
There is deficiency of blood shower to be 237 people, there is aging shower to be 202 people.Subject takes 1 capsule (group of the embodiment of the present invention daily
Close object powder and directly fill capsule), it daily 3 grams, takes points for 3 times, continues 45, before the diet of duration of medication, daily life and medication
Substantially it maintains identical.It after medication, is combined by observation, inquiry, private prosecution, Comprehensive Assessment, it is 5 people that the deficiency of vital energy, which shows unchanged person,
And the performance of remaining popularity void disappears (deficiency of vital energy significantly improves rate up to 97.3%), the deficiency of blood shows unchanged person and is 13 people and remaining people's blood
Void performance disappears (deficiency of blood significantly improves rate up to 94.5%), the unchanged person of aging performance is 14 people and remaining people's aging performance is significant
It reduces (Senescence rate up to 93.1%).These are the result shows that the present composition has the function of that excellent improvement energy and blood of human body prolongs
The effect of slow human senility.
Test example 5: composition is to the effect expedition for improving immunity
Immune is a kind of biological answer-reply process of body " identification " and " exclusion " non-antigen, to maintain intracorporal physiology
Balance.Immunity function is the basis of human health, immune dysfunction and it is low when, the energy of body fight infections can be reduced
Power reduces identification and removes the histocyte ability of itself aging, reduces killing and removes the energy of abnormal sudden change cell in vivo
Power leads to the decline of human body premunition and vis medicatrix naturae.And modern society, the accelerating rhythm of life, the increase of competitive pressure, make to be permitted
More people are in nervous working and learning state, and body, which is chronically at this tense situation, will inhibit immune function;Meanwhile tightly
Working and learning allow more people to have to convenient fast food, the unbalance of endotrophic element is caused, if body is long-term
In a state in which immunity of organisms can be made to decline, the sub-health state of body is eventually led to.A kind of immune guarantor as body
Shield property physiological reaction, the balance and stabilization of vivo environment are maintained by immune function, and immunologic dysfunction is then immunized
Property disease.Scientist's research is immunized according to the U.S., mankind's major part disease is attributed to immune system and goes wrong.Long-term spirit pressure
Power has an important influence the immune function of human body, professor Thomas of Thelma Hopkins medical college of the U.S. to 1337 volunteers into
The observation gone up to 18 years has been found that people is chronically at lonely, contradiction, disappointment, constrains state, just will affect vivo environment
Balance, thus resistance weaken.City now is lived in, everyone health is easy to be on the hazard, including air is dirty
Dye, drinking water pollution, environmental pollution, operating pressure, economic pressures, improper diet, bacterial virus etc., all these unfavorable health
Factor can cause immunity of organisms low, and being usually expressed as people's spirit cannot concentrate, memory loss, frequent burnout, be susceptible to suffer from
The sub-health status such as disease, aging ahead of time.It is more especially the crowd of occupation with mental labour, opposite stress is very big,
So that stress is put aside for a long time, brain overload operation, to cause immunity degradation, weak all over, dizzy eye is puckery, the heart
Throb with fear shortness of breath, insomnia forgetfulness etc..Immunocompromised person, easily catches a cold and epidemic disease, and the low person of permanent immunity power compares healthy population
It is easy to infect, any reason causes compromised immune, then bacterium, virus etc. will assemble in vivo, and cause human body sick.
The intracorporal immune system of people is the best weapons of system, has the effects that the infringement for resisting pathogenic microorganism.
This test example investigates influence of the present composition to mouse immune regulatory function, and specific test is as follows.Reagent and
Grouping: experimental animal is divided into 7 groups, comprising: blank control group (giving water), Capsule Dendrobii group (167mg/kg), example 1 group
Object group, 6 composition group of embodiment, 7 composition group of embodiment, embodiment 8 are closed referring to 1 resulting composition group of embodiment, embodiment 9
Referring to 1 resulting composition group of embodiment;Five kinds of composition components of the invention do not give composition agent in terms of X-factor
Amount is 100mg/kg body weight/day;Test method: according to permitted the new document in day (Xu Tianxin is examined etc., Capsule Dendrobii antifatigue effect,
Zhejiang preventive medicine, 2002,14 (11): the 80) method of its " 4.1 Loaned swimming test ";As a result: blank control group (gives water)
Walking weight load mean value is 268 ± 148 seconds, Capsule Dendrobii group (167mg/kg) walking weight load mean value is respectively 862
± 276 seconds (* *), example 1 group close that object group walking weight load mean value is respectively 1223 ± 293 seconds (* * *), embodiment 6 combines
Object group walking weight load mean value is respectively 1441 ± 316 seconds (* * *), 7 composition group walking weight load mean value of embodiment point
Not Wei 1367 ± 252 seconds (* * *), embodiment 8 referring to 1 resulting composition group walking weight load mean value of embodiment be respectively 515
± 242 seconds (*), embodiment 9 referring to 1 resulting composition group walking weight load mean value of embodiment be respectively 469 ± 213 seconds (*)
[compared with blank control group, * < 0.1, * < 0.01 * * < 0.05, * *].The result shows that excellent biology is presented in the present composition
Effect is learned, has extremely significant difference compared with blank control group, and effect is better than comparison medicine Capsule Dendrobii, is resisted with excellent
Fatigue effect, the long-term effect of this antifatigue effect are the raising of immunity and the elimination of inferior health problem.
Test example 6: composition is to the effect expedition for improving microcirculation
Using MoorVMS-LDF2 Laser Doppler Flowmetry, observing the present composition improves the effect of microcirculation
Fruit.
Animal and grouping: male mice 60,18~20 grams of weight, 6 groups are randomly divided into, every group of 10 animals;Each group is equal
It feeds with standard meal and free water;Administration group A, B, C, D, component E are not fed to 1,6,7 composition of embodiment and embodiment daily
8,91 method resulting composition of embodiment (each group daily dose is calculated as 5mg/kg weight with iron), control group S group animal are respectively referred to
It is not administered to compare.6 groups of animal administrations are tested after nursing 30 days.
Animal preparation: mouse peritoneal injects yellow Jackets 40mg/kg anesthesia, and head center cuts off skin, removes surface
Tissue monitors laser-Doppler blood flow using dental burr by the cerebrovascular under skull wear down to visible skull at the top of the temporo of left side
The laser probe of instrument is fixed on left temporo parietal bone center, sets duration 0.3s, 10 times of amplification, starts timing after stablizing 20min, in
0min, 30min, 60min observation, the microcell blood flow of microcirculation is indicated with voltage value (mv), calculates every animal three observations
3 blood flow mean values at time point, with the blood flow class mean of this 3 mean value computations, 10 animal.
As a result: blood flow class mean is 26.2mv after S group is fed 30;A, after B, C group animal take the present composition
After 30 days blood flow class mean be respectively 39.8mv (increase by 51.9%, compared with S group), 41.3mv (increasing by 57.6%),
38.3mv (increases by 46.2%);D, E group animal takes after the present composition that blood flow class mean is respectively 30.6mv after 30 days
(increasing by 16.8%), 29.7mv (increasing by 13.4%).It can be seen that the effect of excellent improvement microcirculation is presented in the present composition
Fruit.
Test example 7: protective effect of the composition to rat ovary function
Ovary is region more sensitive to radiation in female repro ductive system, with the increase of exposure dose, ovarian function
Damage is also further serious.Ovarian function damage is the one main long term complication of patient for receiving radiotherapy or chemotherapeutic treatment,
Large dosage of, prolonged chemotherapy will damage the ovarian function of each age group patient, lead to amenorrhoea, fecundity decline or funeral
It loses.It establishes effective animal model and has very important significance to inquire into protection ovarian function.People are usually according to rat
The regularity of oestrous cycle assess its ovarian function, however these method times are long, be unfavorable for rapidly evaluating ovary function
Can, it is unfavorable for effect of the Fast Evaluation drug to protection ovarian function.It is interior that contact radioactive ray can cause ovarian function damage to cause
It is disorderly often to will appear menstruation after women large dosage contacts radioactive ray (such as radiotherapy) for secreting function disorder and reproductive function decline
The symptoms such as unrest, amenorrhoea.This test causes rat ovary hypokinetic with the preparation radiotherapy of clinac full-body exposure rat
Model studies the protective effect that the present composition damages caused by radiation ovarian function on rat model.This test radiation
Line evaluates the damage of rat ovary function the effect of drug, has the characteristics that intuitive, efficient.
Test method: cleaning grade SD female rats (180~200g of weight), pellet feed, freely ingest, room temperature 20
~25 DEG C, relative humidity 45%~55%, daily illumination 12h, after raising 3d is familiar with environment, whens daily morning 8, takes vaginal fluid
Smear om observation sexual cycle, selection have the animal in normal sexual cycle to enter experiment.Rat 35 of choosing qualification are taken into, at random
Be divided into five groups: (a) control group, (b) radiation exposure group (i.e. RT group), (c) RT+ example 1 group close object group, (d) RT+ embodiment 6
Composition group, 7 composition group of (e) RT+ embodiment.Each group continues to feed using aforementioned condition, wherein (c), (d), (e) group it is daily
It gives composition (the composition daily dose of each group is calculated as 5mg/kg weight with iron), after feeding 45, (b)~(e) four groups of references
Li Caixia etc. [Li Caixia waits building [J] the Third Military Medical University journal of mouse model of premature ovarian failure, 2008,30 (6):
506-510] method, every animal be followed by by total amount be 200cGy radiation exposure, irradiate speed 50cGy/min, irradiation field 30cm
× 30cm, irradiation distance 150cm.Each group rat takes vaginal fluid smear om observation emotionally all daily after radiation exposure
Phase puts to death rat in anoestrum in 2 weeks after irradiation, and the arch of aorta takes blood.Bilateral ovaries are taken, 4% paraformaldehyde of right ovary is solid
Fixed, left ovary is stored in liquid nitrogen container.Using E2, FSH in ELISA method measurement rat blood serum.Rat aorta bow blood sampling, separation
Serum is carried out by AMEKO Reagent Company ELISA kit operating instruction.Histomorphological and ovarian follicle count: right ovary
Paraffin embedding, HE is dyed after taking greatest cross-section to be sliced, and the follicle number with growing follicle structure is counted under light microscopic, is counted respectively
Primordial follicle, primary follicle, secondary follicle and the graaffian follicle of each group rat.Caspase3 measurement: it is surveyed using spectrophotometry
Determine the activity of rats with left ovary tissue caspase3.Since caspase3 can catalysis substrate Ac-DEVD-pNA generation yellow
Matter pNA, therefore the activity of caspase3 can be measured in the absorbance of 405nm by measurement pNA.Kit purchases the green skies
Biotechnology company is carried out by kit operating instruction.All indexs carry out statistical analysis using 18.0 software of SPSS.Meter
Amount Data Detection result is indicated with mean ± standard deviation (x ± s);Comparison one-way analysis of variance (One- between multiple groups mean
Way ANOVA);Compare two-by-two between group, is examined when meeting homogeneity of variance using LSD method;If heterogeneity of variance, compare two-by-two using base
It is examined in the conservative Tambane's T2 that t is examined, is that difference is statistically significant with P≤0.05.
Test result: rat serum E2 level (pmol/L) after radiation exposure: control group is that 6.93 ± 0.58, RT group is 2.71
± 0.44*, RT+ example 1 group are 5.34 ± 0.37*#, 6 groups of RT+ embodiment be 4.92 ± 0.49*#, 7 groups of RT+ embodiment be
5.56±0.68*#;Rat serum FSH level (ng/L) after radiation exposure: control group be 0.323 ± 0.021, RT group be 0.642 ±
0.017*, RT+ example 1 group are 0.416 ± 0.022*#, 6 groups of RT+ embodiment be 7 groups of 0.451 ± 0.025*#, RT+ embodiment
For 0.427 ± 0.013*#;Rat total follicular number (a) after radiation exposure: control group be 22.43 ± 2.21, RT group be 10.32 ±
2.18*, RT+ example 1 group are 19.73 ± 1.93*#, 6 groups of RT+ embodiment be 20.12 ± 1.88*#, 7 groups of RT+ embodiment be
18.47±2.33*#;Rat ovary tissue capase3 activity change (is characterized with pNA in the A value of 405nm): control group is
0.133 ± 0.042, RT group be 0.576 ± 0.044*, RT+ example 1 group be 0.303 ± 0.024*#, 6 groups of RT+ embodiment be
0.297 ± 0.046*#, 7 groups of RT+ embodiment be 0.317 ± 0.051*#;Change under rat ovary tissue light microscopic: control group ovary
It is clear in structure, visible primordial follicle in ovary, developmental ovarian follicles and graaffian follicle at different levels;Its visible cortex of RT group ovary increases
Thickness, structure is chaotic, interstitial fibrosis, and original follicle number amount is sparse in cortex, and growing follicles at different levels fall sharply with graaffian follicle number,
See a large amount of atretic follicles and multiple big outmoded sample luteal tissues;Three ovarian structures for giving composition group animal are clear, ovum
Visible primordial follicle in nest, developmental ovarian follicles and graaffian follicle at different levels, and visible a small amount of atretic follicle and corpus luteum sample substance;On
It states in result, compared with the control group P < 0.05 *, #P < 0.05 compared with RT group.
The above results show that the present composition can prevent radioactive ray to the detrimental effect of ovarian function, are conducive to mention
High female ovary function improves the improvement that female ovary function is able to reflect female skin in view of as described above, because
This present composition can equally improve female skin, such as avoid face's jaundice, dry skin, cutis laxa coarse etc.
Deng.
It is obvious to a person skilled in the art that invention is not limited to the details of the above exemplary embodiments, Er Qie
In the case where without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter
From the point of view of which point, the present embodiments are to be considered as illustrative and not restrictive, and the scope of the present invention is by appended power
Benefit requires rather than above description limits, it is intended that all by what is fallen within the meaning and scope of the equivalent elements of the claims
Variation is included within the present invention.
Claims (10)
1. purposes of the pharmaceutical composition in the drug that preparation improves female skin for improving female ovary function, the drug
It include X-factor and diluent in composition.
2. a kind of pharmaceutical composition, wherein including X-factor and diluent.
3. pharmaceutical composition according to claim 1, wherein the diluent is selected from: starch, sucrose, lactose, microcrystalline cellulose
Element, calcium monohydrogen phosphate.
4. pharmaceutical composition according to claim 1, wherein also including phosphatide;Such as egg yolk lecithin, soybean lecithin.
5. pharmaceutical composition according to claim 1, wherein comprising 100 parts by weight of X-factor, diluent 100~
1000 parts by weight, phosphatidase 2~25 parts by weight.
6. pharmaceutical composition according to claim 1, wherein comprising 100 parts by weight of X-factor, diluent 100~
750 parts by weight, phosphatidase 5~15 parts by weight.
7. pharmaceutical composition according to claim 1, wherein comprising 100 parts by weight of X-factor, diluent 100~
500 parts by weight, phosphatidase 5~10 parts by weight;Such as 100 parts by weight of X-factor, 300 parts by weight of diluent, phosphatide 7.5
Parts by weight;Alternatively, the pharmaceutical composition is prepared according to the method included the following steps: keeping X-factor preparatory
It is crushed to the fine powder that can pass through 100 mesh screens;Phosphatide is set to be dissolved in the solution that concentration 20~25% is made in ethyl alcohol;30~
It is blood red that phospholipid solution is sprayed to the ferric sesquichloride in fluidized state in 35 DEG C of fluidizing equipment (such as fluidised bed granulator)
In plain fine powder, continues fluidisation and remove ethyl alcohol;The diluent that 20~30 parts by weight are added is uniformly mixed, and is suppressed material with extruder
Slabbing object;This tablet is set -20~-15 DEG C to freeze 24~30 hours;Tablet is crushed, it is mixed that balance diluents are added
, continue to be crushed to and can obtain composition by the fine powder of 60 meshes;Preparation optionally is made in the composition of fine-powdered in this
Form.
8. pharmaceutical composition according to claim 1, wherein the dosage form be tablet, capsule, soft capsule, pill,
Any applicable dosage form of powder, granule, electuary, oral mixed suspension liquor, dry suspensoid agent, paste, jelly agent etc.;It is preferred that
Dosage form be tablet, capsule, soft capsule, granule, dry suspensoid agent.
9. pharmaceutical composition according to claim 1, being used to improve female ovary function improves female skin.
It include ferric sesquichloride blood in described pharmaceutical composition 10. the method for preparing any one of claim 2~9 pharmaceutical composition
Red pigment and diluent;This method comprises the following steps: being crushed to X-factor in advance can be by the thin of 100 mesh screens
Powder;Phosphatide is set to be dissolved in the solution that concentration 20~25% is made in ethyl alcohol;In 30~35 DEG C of fluidizing equipments (such as fluidized bed
Granulator) in phospholipid solution is sprayed in the X-factor fine powder in fluidized state, continue fluidisation remove ethyl alcohol;
The diluent that 20~30 parts by weight are added is uniformly mixed, and material is compressed into tablet form object with extruder;This tablet is set -20
~-15 DEG C freeze 24~30 hours;Tablet is crushed, balance diluents are added and are mixed, continuing to be crushed to can be by 60 mesh
Fine powder, obtain composition;Dosage form optionally is made in the composition of fine-powdered in this.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811421520.4A CN109331022B (en) | 2018-11-25 | 2018-11-25 | Composition for improving female ovarian function and female skin and preparation process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811421520.4A CN109331022B (en) | 2018-11-25 | 2018-11-25 | Composition for improving female ovarian function and female skin and preparation process thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109331022A true CN109331022A (en) | 2019-02-15 |
CN109331022B CN109331022B (en) | 2020-10-30 |
Family
ID=65317923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811421520.4A Active CN109331022B (en) | 2018-11-25 | 2018-11-25 | Composition for improving female ovarian function and female skin and preparation process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109331022B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101708184A (en) * | 2009-12-11 | 2010-05-19 | 河北师范大学 | Medicine application of iron liposome |
CN108065207A (en) * | 2016-11-13 | 2018-05-25 | 威海南波湾生物技术有限公司 | A kind of X-factor health food |
-
2018
- 2018-11-25 CN CN201811421520.4A patent/CN109331022B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101708184A (en) * | 2009-12-11 | 2010-05-19 | 河北师范大学 | Medicine application of iron liposome |
CN108065207A (en) * | 2016-11-13 | 2018-05-25 | 威海南波湾生物技术有限公司 | A kind of X-factor health food |
Non-Patent Citations (3)
Title |
---|
周水秀 等: "《血红素加氧酶-1在缺血性脑损伤中的保护作用》", 《咸宁学院学报(医学版)》 * |
广东美丽康保健品有限公司: "《澳天力牌氯化高铁血红素软胶囊》", 《国食健字G20120093》 * |
格美汇大本营: "《气血虚怎么调理 做个漂亮女人》", 《HTTPS://TIEBA.BAIDU.COM/P/3524132365?RED_TAG=2391247757》 * |
Also Published As
Publication number | Publication date |
---|---|
CN109331022B (en) | 2020-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552698A (en) | Medicinal application of dendrobium candidum | |
CN109718303A (en) | Improving the skin maintenance and cosmetic benefits of female ovary function improves the Chinese medicine composition of female skin | |
CN109939153A (en) | A kind of anaesthetic for treating enteritis and preparation method thereof and preparation and preparation method | |
CN108434239A (en) | Fill blood Antifatigue oral liquid and preparation method thereof | |
KR20010029771A (en) | Compound preparations of Chinese traditional medicine for diabetes | |
CN102008083B (en) | Health food for alleviating physical fatigue and removing chloasma | |
CN101168051A (en) | Application of sea collagen peptide as preparation of anti-oxidation medicine, health-care food, food or cosmetics | |
CN109223766A (en) | Improve the composition and preparation process that microcirculation in human body improves the immunity of the human body | |
Stephens | Endocrine factors in undernutrition | |
CN109331022A (en) | Improving female ovary function improves the composition and preparation process of female skin | |
CN108853223A (en) | A kind of intelligence system emplastrum and preparation method thereof for treating children's real example | |
CN103719661B (en) | Blood-enriching oral liquid health products | |
CN109481446B (en) | Composition for improving body functions of pregnant woman, lying-in woman and lactating mother and fetus and preparation process | |
CN109223802A (en) | Improve composition and preparation process that human body hemoglobin inhibits artery sclerosis | |
Wood et al. | The practice of medicine | |
CN109223803A (en) | Improve the composition and preparation process of energy and blood of human body function delaying human body caducity | |
CN107737108B (en) | A kind of combination of oral medication for treating Pathogenesis of Post-infarction Ventricular Remodeling | |
CN109718304A (en) | Improve the Chinese medicine composition of the microcirculation of human body cardio and vascular function and pre- preventing thrombosis | |
CN109718305A (en) | Improve energy and blood of human body function and improves the Chinese medicine composition that resist oxygen lack delays senescence | |
CN106798826A (en) | Tuber of dwarf lilyturf oligosaccharides is preparing the application in promoting brown fat generation medicine | |
Ali et al. | Severe Hypophosphatemia Following Ferric Carboxymaltose in a Patient With Inflammatory Bowel Disease | |
Kellogg | OXYGEN ENEMATA AS A REMEDY IN CERTAIN DISEASES OF THE LIVER AND INTESTINAL TRACT.: Read in the Section on Practical Medicine, at the Thirty-ninth Annual Meeting of the American Medical Association, May, 1888. | |
Ansari et al. | Thyrotoxicosis in a mongol. | |
Melnikova et al. | Pathophysiology of Organs and Systems | |
CN109731046A (en) | Improve the Chinese medicine composition of the Chinese medicine composition of human body renal function enhancing human body kidney qi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Composition and preparation process for improving female ovarian function and skin Effective date of registration: 20220601 Granted publication date: 20201030 Pledgee: Zhangshu Shunyin Village Bank Co.,Ltd. Pledgor: JIANGXI TIANYUAN PHARMACEUTICAL CO.,LTD. Registration number: Y2022980006899 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |